The development of ovulation-inducing drugs has enabled clinicians to more effectively treat
the hypothalamic, pituitary, and ovarian abnormalities resulting in infertility. Pregnancy rates …

Disorders of ovulation resulting in impaired fertility constitute one of the most common
causes of involuntary childlessness. Medications to cause or at least facilitate ovulation have …

Ovulation-induction agents are commonly used in the treatment of infertility in patients with
or without ovulatory disturbances. These agents include Clomifene, bromocriptine …

Many couples faced with infertility are treated with ovulation inducing medicines. Recently,
concerns have been raised about the possible risk of ovarian malignancy after such ovarian …

The drugs currently available for ovulation induction have been in widespread use since
1960, most commonly in anovulatory women. These patients may be anovulatory because …

Involuntary infertility is an increasing problem in this era of delayed childbearing.
Fortunately, many advances have been made recently in the medical and surgical treatment …

Objective To review critically the published data regarding the proposed association of
ovulation induction, infertility, and an increased risk of ovarian cancer. Design A medline …

OBJECTIVE: To critically examine the possible association between ovulation-inducing
drugs and ovarian cancer. DESIGN: Medline literature review and cross-reference of …

The drugs used in in vitro fertilisation (IVF) procedures have the ability to stimulate the
ovaries either directly or indirectly to cause multiple follicular development. In most centres …

Background: The task of reproductive medicine is to make the effort to enable safe
conception for all couples desiring it. Induction of ovulation with gonadotropins is one of the …